new weight loss drug retatrutide Demand for Unapproved Weight-Loss Surges on Social Media drmcgowan was just featured in
Description
In addition, the All of Us Research Program would not be possible without the partnership of its participants. Conflict of interest The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Tirzepatide won on both primary endpoints: total body weight reduction and waist circumference reduction at 72 weeks
It might enhance metabolic health indicators, like insulin sensitivity and glycemic control, which are crucial for individuals dealing with obesity or associated disorders
It will be very hard to estimate the precise impact
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
Hassan L, Newman L, Keast R, Danaher J, Biesiekierski JR
